(Q44183936)

30 November 2017

title

Prospective trial of cryosurgical ablation of the prostate: five-year results (English)

1 reference

30 November 2017

Donnelly BJ

1

1 reference

30 November 2017

Saliken JC

2

1 reference

30 November 2017

Ernst DS

3

1 reference

30 November 2017

Ali-Ridha N

4

1 reference

30 November 2017

Brasher PM

5

1 reference

30 November 2017

Robinson JW

6

1 reference

30 November 2017

Rewcastle JC

7

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

60

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

645-649

1 reference

Cryosurgery in prostatic cancer: survival

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Outcome and safety of transrectal US-guided percutaneous cryotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Salvage cryotherapy for recurrent prostate cancer after radiation therapy: the Columbia experience

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Role of radical prostatectomy in patients with prostate cancer of high Gleason score

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Contemporary results of anatomic radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Three-dimensional conformal therapy or standard irradiation in localized carcinoma of prostate: preliminary results of a nonrandomized comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

3D conformal radiation therapy (3DCRT) for high grade prostate cancer: a multi-institutional review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Conformai external beam treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

Palladium-103 brachytherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

The development of erectile dysfunction in men treated for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901839-3

7 January 2021

10.1016/S0090-4295(02)01839-3

Identifiers

DOI

1 reference

30 November 2017

1 reference